Palatin Technologies Inc. (PTN)

[BesaoT35]

Thanks bigbut. I use bremelanotide myself and experience a horniness that I have not experienced since being a teenager. I suspect that there are other men who will have a similar beneficial effect. Women are different and may not get that sort of benefit. Once older men who are with attractive significantly younger female sexual partners find out about Brem it could be in for large sales IMO.

We still have the rest of the world to sell into including Europe and Japan. We also have a pipeline of other drugs coming through trials for premature birth and cardiac indications I believe. I bought in at average price 56 cents many years ago. I have 42000 shares. I am thinking to sell at $5.00. Is this unreasonable?

Why would the first scientifically demonstrated aphrodisiac be a failure in the marketplace? Is management incompetent or corrupt? Will generic unlicensed sales of bremelanotide undercut licensed royalty paying sales?